5-Chloropyrazolo(1,5-a)pyrimidine
Grundinformationen
- CAS
29274-24-6- Standard-SMILES
Clc1ccn2nccc2n1- InChIKey
WEPRLWNMBTYGGD-UHFFFAOYSA-N- Summenformel
- C6H4ClN3
- Durchschnittliche Molmasse
- 153,57 g/mol
- Monoisotopische Masse
- 153,00937481
Namen und Bezeichner
- Bevorzugter Name
- 5-Chloropyrazolo(1,5-a)pyrimidine
- IUPAC
- 5-chloropyrazolo[1,5-a]pyrimidine
- Englischer Name
- 5-Chloropyrazolo[1,5-a]pyrimidine
- Summenformel
- C6H4ClN3
- Molmasse
- 153.57
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
29274-24-6- PubChem CID
- 21071759
- DTXSID
DTXSID40610501- EC Number
- 812-022-5
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1,3
- Polarare Oberfläche (TPSA)
- 30,2 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 10
- Formalladung
- 0
- Komplexität
- 130
Physikochemische Eigenschaften
- Dichte
- 1.51 · 1.51±0.1 g/cm3(Predicted)
- storage temp.
- 2 · under inert gas (nitrogen or Argon) at 2-8°C
- pka
- -0.49 · -0.49±0.30(Predicted)
- InChI
- InChI=1S/C6H4ClN3/c7-5-2-4-10-6(9-5)1-3-8-10/h1-4H
- InChIKey
- WEPRLWNMBTYGGD-UHFFFAOYSA-N
- SMILES
- C12=CC=NN1C=CC(Cl)=N2
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Sicherheitsdaten
- ridadr
- UN2811
- hs_code
- 2933599590
- hazard_class
- IRRITANT
Chemie und Industrie
Anwendungen
Beschreibung5-Chloropyrazolo[1,5-a]pyrimidine is formed by replacing the hydrogen atom at position 5 of the pyrazolo[1,5-a]pyrimidine compound structure with a chlorine atom. It can serve as a pharmaceutical intermediate for synthesising other bioactive compounds. Pyrazolo[1,5-a]pyrimidine derivatives function as ATP-competitive and allosteric inhibitors of protein kinases, with those targeting the epidermal growth factor receptor (EGFR) demonstrating potential in the treatment of non-small cell lung cancer (NSCLC).
Verwenden5-Chloropyrazolo[1,5-a]pyrimidine was used in the preparation of β-substituted biarylphenylalanine amides as selective amino amide dipeptidyl peptidase IV inhibitors for treatment of type 2 diabetes.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter100 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…